{
    "year": 109,
    "term": 1,
    "name": "生醫領域開發與商化概述",
    "teachers": [
        "柯承志"
    ],
    "department": "SU43",
    "code": "BIC9049",
    "credit": 2,
    "serial": 2987,
    "group": "",
    "quota": {
        "limit": 50,
        "additional": 20
    },
    "schedule": [
        {
            "day": 4,
            "from": 3,
            "to": 4,
            "campus": "公館",
            "classroom": "Ｓ504"
        }
    ],
    "programs": [],
    "comment": "",
    "restrict": "",
    "form_s": "",
    "classes": "9",
    "dept_group": "",
    "hours": 2,
    "description": "生醫產業面臨全球化的發展趨勢，開發者須及早瞭解風險管理的相關規定、執行方式以及適當的系統，進而有效將管理納入品質系統與產品開發活動，才能確保產品符合各國衛生主管機關對醫療器材的法規要求，順利將產品推至全球市場。",
    "goals": [
        "協助與課學員瞭解開發之目的性",
        "協助與課學員瞭解開發相關之法規",
        "協助與課學員瞭解分析安全性與有效性",
        "協助與課學員瞭解上市前準備"
    ],
    "syllabus": "本課程聘請由相關專科醫師學者授課\n\n1從實驗室到商品\n\n2實驗室管理需求\n\n3內部稽核與管理審查\n\n4儀器設備管理\n\n5文件與紀錄\n\n6生物相容性評估\n\n7有效性評估\n\n8滅菌方式與確效\n\n9期中報告(書面)\n\n10GLP實驗室概述\n\n11ISO 13485概述\n\n12FDA 510 K I\n\n13FDA 510 K II\n\n14臨床試驗相關設計與規範\n\n15全球化布局以及商品保護手段\n\n16期末報告\\-1(上台口頭報告)\n\n17期末報告\\-2(上台口頭報告)\n\n18期末結報(策略規劃書)",
    "methodologies": [
        {
            "type": "講述法",
            "note": "講者口述"
        },
        {
            "type": "討論法",
            "note": "依學生人數看分組狀況，於期中前提出一預計開發之商品"
        },
        {
            "type": "問題解決教學",
            "note": "從期中報告延伸，進行討論"
        },
        {
            "type": "實驗/實作",
            "note": "針對期中報告於每堂課進行修改"
        },
        {
            "type": "專題研究",
            "note": "期末完成策略規劃書"
        }
    ],
    "grading": [
        {
            "type": "課堂討論參與",
            "weight": 10,
            "note": ""
        },
        {
            "type": "報告",
            "weight": 30,
            "note": ""
        },
        {
            "type": "專題",
            "weight": 60,
            "note": ""
        }
    ],
    "prerequisite": "",
    "general_core": []
}